Comparative effectiveness of ozanimod versus dimethyl fumarate: results of a matching-adjusted indirect comparison

被引：0
|
作者：
Cohan, S. [1 ]
Kumar, J. [2 ]
Arndorfer, S. [3 ]
Zhu, X. [3 ]
Zivkovic, M. [3 ]
Tencer, T. [2 ]
机构：
[1] Providence Multiple Sclerosis Ctr, Portland, OR USA
[2] Bristol Myers Squibb, Princeton, NJ USA
[3] Genesis Res, Hoboken, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2020年 / 26卷 / 3_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P0046
引用
收藏
页码：140 / 140
页数：1
相关论文
共 50 条
  • [21] Comparative effectiveness using a matching-adjusted indirect comparison between delayed-release dimethyl fumarate and fingolimod for the treatment of relapsing-remitting multiple sclerosis
    Fox, R. J.
    Cutter, G.
    Chan, A.
    Xiao, J.
    Okwuokenye, M.
    Levison, D.
    Lewin, J. B.
    Edwards, M. R.
    Marantz, J. L.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 : 530 - 531
  • [22] Comparative effectiveness and safety of ozanimod versus other oral DMTs in relapsing-remitting multiple sclerosis: a synthesis of matching-adjusted indirect comparisons
    Paul, Damemarie
    Swallow, Elyse
    Patterson-Lomba, Oscar
    Branchcomb, Tychell
    N'Dri, Laetitia
    Gomez-Lievano, Andres
    Liu, Jingyi
    Dua, Akanksha
    Mcginley, Marisa
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2024, 17
  • [23] SECUKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS: COMPARATIVE EFFECTIVENESS RESULTS VERSUS ADALIMUMAB UP TO 48 WEEKS USING A MATCHING-ADJUSTED INDIRECT COMPARISON
    Nash, P.
    McInnes, I. B.
    Mease, P.
    Thom, H.
    Cure, S.
    Palaka, E.
    Gandhi, K.
    Mpofu, S.
    Jugl, S.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 353 - 354
  • [24] Comparative efficacy of diroximel fumarate, ozanimod and interferon beta-1a for relapsing multiple sclerosis using matching-adjusted indirect comparisons
    Jiang, Tammy
    Shanmugasundaram, Mathura
    Bozin, Ivan
    Freedman, Mark S.
    Lewin, James B.
    Shen, Changyu
    Ziemssen, Tjalf
    Arnold, Douglas L.
    JOURNAL OF COMPARATIVE EFFECTIVENESS RESEARCH, 2024, 13 (10)
  • [25] A Matching-Adjusted Indirect C\omparison of Ozanimod to Diroximel Fumarate in Patients with Relapsing-Remitting Multiple Sclerosis
    McGinley, M.
    Paul, D.
    Branchcomb, T.
    Arndorfer, S.
    Navickas, C.
    Gupte-Singh, K.
    Kantor, D.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 39 - 39
  • [26] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Nash, Peter
    McInnes, Iain B.
    Mease, Philip J.
    Thom, Howard
    Hunger, Matthias
    Karabis, Andreas
    Gandhi, Kunal
    Mpofu, Shephard
    Jugl, Steffen M.
    RHEUMATOLOGY AND THERAPY, 2018, 5 (01) : 99 - 122
  • [27] Secukinumab Versus Adalimumab for Psoriatic Arthritis: Comparative Effectiveness up to 48 Weeks Using a Matching-Adjusted Indirect Comparison
    Peter Nash
    Iain B. McInnes
    Philip J. Mease
    Howard Thom
    Matthias Hunger
    Andreas Karabis
    Kunal Gandhi
    Shephard Mpofu
    Steffen M. Jugl
    Rheumatology and Therapy, 2018, 5 : 99 - 122
  • [28] Matching-Adjusted Indirect Comparisons: A New Tool for Timely Comparative Effectiveness Research
    Signorovitch, James E.
    Sikirica, Vanja
    Erder, M. Haim
    Xie, Jipan
    Lu, Mei
    Hodgkins, Paul S.
    Betts, Keith A.
    Wu, Eric Q.
    VALUE IN HEALTH, 2012, 15 (06) : 940 - 947
  • [29] Comparative effectiveness of upadacitinib versus ustekinumab in patients with moderately to severely active Crohn's disease: a matching-adjusted indirect comparison
    Ma, C.
    Dubinsky, M. C.
    Axelrad, J.
    Anyanwu, S.
    Tran, J.
    Lacerda, A.
    Joshi, N.
    Griffith, J.
    JOURNAL OF CROHNS & COLITIS, 2024, 18 : I1866 - I1867
  • [30] Synthesis of Matching-Adjusted Indirect Comparisons of Ozanimod for Relapsing Remitting Multiple Sclerosis
    Paul, D.
    Swallow, E.
    Patterson-Lomba, O.
    Branchcomb, T.
    Gomez-Lievano, A.
    Liu, J.
    Dua, A.
    McGinley, M.
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 47 - 47
12345